HeartSciences (HSCS) Research & Development (2021 - 2026)
HeartSciences' (HSCS) quarterly Research & Development came in at $476205.0 in Q2 2026, down 48.75% YoY from $929091.0 in Q2 2025, and down 34.5% on a QoQ basis from $727026.0 in Q4 2025.
HeartSciences (HSCS) Research & Development (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has 6 years of Research & Development data on file, last reported at $476205.0 in Q2 2026.
- Quarterly Research & Development fell 48.75% year-over-year to $476205.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.1 million (down 28.65% YoY) and the FY2026 annual result came in at $2.8 million, down 35.27% from the prior year.
- Research & Development slipped to $476205.0 in Q2 2026, from $727026.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.4 million in Q2 2022 to a low of $434198.0 in Q3 2022.
- A 5-year average of $822388.8 and a median of $757303.0 in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development slumped 60.58% — and 2024, when it surged 116.56%.
- Tracing HSCS's Research & Development over 5 years: stood at $848976.0 in 2022, then declined by 10.8% to $757303.0 in 2023, then soared by 58.32% to $1.2 million in 2024, then plunged by 39.36% to $727026.0 in 2025, then sank by 34.5% to $476205.0 in 2026.
- The last three Research & Development figures came in at $476205.0 (Q2 2026), $727026.0 (Q4 2025), and $997206.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 28.60 Mn |
| 10 | HeartSciences | 6.60 Mn | 4.90 Mn | - | 476,205.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 476,205.00 |
| Oct 31, 2025 | 727,026.00 |
| Jul 31, 2025 | 997,206.00 |
| Apr 30, 2025 | 929,091.00 |
| Jan 31, 2025 | 1.03 Mn |
| Oct 31, 2024 | 1.20 Mn |
| Jul 31, 2024 | 1.22 Mn |
| Apr 30, 2024 | 1.05 Mn |
| Jan 31, 2024 | 509,507.00 |
| Oct 31, 2023 | 757,303.00 |
| Jul 31, 2023 | 565,632.00 |
| Apr 30, 2023 | 534,436.00 |
| Jan 31, 2023 | 643,258.00 |
| Oct 31, 2022 | 848,976.00 |
| Jul 31, 2022 | 434,198.00 |
| Apr 30, 2022 | 1.36 Mn |
| Jan 31, 2022 | 699,015.00 |
| Oct 31, 2021 | 545,773.00 |
| Jul 31, 2021 | 401,114.00 |